M ePQS - External Guidance – API Prequalification Application - Wizard Guidance PDF Guideline/guidance
M ePQS - External Guidance – APIMF Post-PQ Change Application - Wizard Guidance PDF Guideline/guidance
M Example of a Completed Application for a New Version of an Active Pharmaceutical Ingredient Master File (APIMF) PDF Guideline/guidance
M Example of a Completed Application for an Amendment to an Active Pharmaceutical Ingredient Master File (APIMF) PDF Guideline/guidance
M Expression of interest to national regulatory authority (NRA) in the assessment and accelerated national registration, acceptance by NRA and notification of procedure outcomes, Appendix 3, Part A PDF Template
M Expression of interest to participate in the system of peer audits within the network of quality control laboratories involved in WHO prequalification (1 October 2016) DOCX Application form
M Famy Care's ethinylestradiol/levonorgestrel with ferrous fumarate placebo tablets prequalified PDF Guideline/guidance
M FAQ: Active pharmaceutical ingredient (API) micronization (13 September 2019) PDF Guideline/guidance
M FAQ: WHO Collaborative Procedure between WHO and National Medicines Regulatory Authorities in Assessment and Accelerated National Registration PDF Guideline/guidance
M Frequently Asked Questions (FAQ) - WHO Pilot Procedure for Prequalification of Biotherapeutic Products: rituximab and trastuzumab PDF Guideline/guidance
M Frequently asked questions by the manufacturing, trial and testing organizations in connection with some of their constraints faced during the COVID-19 outbreak PDF Information note
M Guidance - Nitrosamine contamination policy for Active Pharmaceutical Ingredients PDF Guideline/guidance
M Guidance on amendments to an active pharmaceutical ingredient master file (APIMF) submitted in support of a prequalified finished pharmaceutical product (FPP) or prequalified API PDF Guideline/guidance
M Guidance on plain language descriptions of visual appearance for oral dosage forms in WHOPARs PDF Guideline/guidance
M Guidance on the Submission of Applications for Prequalification of Zinc Tablets and Zinc Oral Liquid (Solution) PDF Guideline/guidance
M Guideline on bioanalytical method validation and study sample analysis, TRS 1060, Annex 6 (2025) PDF Guideline/guidance
M Guideline on bioanalytical method validation and study sample analysis, TRS 1060, Annex 6 (2025) PDF
M V Guidelines for good clinical practice (GCP) for trials on pharmaceutical products - TRS 850 PDF Guideline/guidance